Skip to main navigation Skip to search Skip to main content

Post-diagnostic use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of prostate cancer-specific mortality

Research output: Contribution to conferencePoster

Original languageEnglish
Publication statusUnpublished - 29 Nov 2013
EventUKCRC Centre of Excellence for Public Health Away Day 2013 - , United Kingdom
Duration: 29 Nov 201329 Nov 2013

Other

OtherUKCRC Centre of Excellence for Public Health Away Day 2013
Country/TerritoryUnited Kingdom
Period29/11/201329/11/2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this